Loading…

Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells

A novel trimethyltin(IV) complex (Me3SnL), derived from 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoate ligand, has been synthesized and characterized by elemental microanalysis, UV/Vis spectrophotometry, FT-IR and multinuclear ([sup.1] H, [sup.13] C and [sup.119] Sn) NMR spectroscopies. Furthermore,...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2024-03, Vol.17 (3)
Main Authors: Kasalović, Marijana P, Dimić, Dušan, Jelača, Sanja, Maksimović-Ivanić, Danijela, Mijatović, Sanja, Zmejkovski, Bojana B, Schreiner, Simon H. F, Rüffer, Tobias, Pantelić, Nebojša Đ, Kaluđerović, Goran N
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 3
container_start_page
container_title Pharmaceuticals (Basel, Switzerland)
container_volume 17
creator Kasalović, Marijana P
Dimić, Dušan
Jelača, Sanja
Maksimović-Ivanić, Danijela
Mijatović, Sanja
Zmejkovski, Bojana B
Schreiner, Simon H. F
Rüffer, Tobias
Pantelić, Nebojša Đ
Kaluđerović, Goran N
description A novel trimethyltin(IV) complex (Me3SnL), derived from 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoate ligand, has been synthesized and characterized by elemental microanalysis, UV/Vis spectrophotometry, FT-IR and multinuclear ([sup.1] H, [sup.13] C and [sup.119] Sn) NMR spectroscopies. Furthermore, the structure of the ligand precursor HL was solved using SC-XRD (single-crystal X-ray diffraction). The prediction of UV/Vis and NMR spectra by quantum-chemical methods was performed and compared to experimental findings. The protein binding affinity of Me3SnL towards BSA was determined by spectrofluorometric titration and subsequent molecular docking simulations. Me3SnL has been evaluated for its in vitro anticancer activity against three human cell lines, MCF-7 (breast adenocarcinoma), A375 (melanoma) and HCT116 (colorectal carcinoma), and three mouse tumor cell lines, 4T1 (breast carcinoma), B16 (melanoma) and CT26 (colon carcinoma), using MTT and CV assays. The strong inhibition of A375 cell proliferation, ROS/RNS upregulation and robust lipid peroxidation lead to autophagic cell death upon treatment with Me3SnL.
doi_str_mv 10.3390/ph17030372
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A788252283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788252283</galeid><sourcerecordid>A788252283</sourcerecordid><originalsourceid>FETCH-LOGICAL-g673-4e5598c3a492943a1ecb06a85532409c55b950506593529e174a2716be314f323</originalsourceid><addsrcrecordid>eNptjE1Lw0AYhBdRsFYv_oIFz9H9zGaPIX5UaNFD7-Xt5k2zstmEbAr67w3qoQeZwwzDM0PILWf3Ulr2MLTcMMmkEWdkwZVQWSGUOT_Jl-QqpQ_GtOGKL0jYjr7Dqf0Kk4_D2A8Qe5iQVnBMmOjaD76m7zj2n76Gyfcx22DtZ6Km5XHqhxYO3tEKQ6CPCFNLfaSrYweRbjDMXx3QUhr9Q6RrctFASHjz50uyfX7aVqts_fbyWpXr7JAbmSnU2hZOgrLCKgkc3Z7lUGgthWLWab23mmmWayu1sMiNAmF4vkfJVSOFXJK739sDBNz52PTTCK7zye1KUxRCC1HImbr_h5pVY-ddH7Hxc38y-AatW2dI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central Free</source><creator>Kasalović, Marijana P ; Dimić, Dušan ; Jelača, Sanja ; Maksimović-Ivanić, Danijela ; Mijatović, Sanja ; Zmejkovski, Bojana B ; Schreiner, Simon H. F ; Rüffer, Tobias ; Pantelić, Nebojša Đ ; Kaluđerović, Goran N</creator><creatorcontrib>Kasalović, Marijana P ; Dimić, Dušan ; Jelača, Sanja ; Maksimović-Ivanić, Danijela ; Mijatović, Sanja ; Zmejkovski, Bojana B ; Schreiner, Simon H. F ; Rüffer, Tobias ; Pantelić, Nebojša Đ ; Kaluđerović, Goran N</creatorcontrib><description>A novel trimethyltin(IV) complex (Me3SnL), derived from 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoate ligand, has been synthesized and characterized by elemental microanalysis, UV/Vis spectrophotometry, FT-IR and multinuclear ([sup.1] H, [sup.13] C and [sup.119] Sn) NMR spectroscopies. Furthermore, the structure of the ligand precursor HL was solved using SC-XRD (single-crystal X-ray diffraction). The prediction of UV/Vis and NMR spectra by quantum-chemical methods was performed and compared to experimental findings. The protein binding affinity of Me3SnL towards BSA was determined by spectrofluorometric titration and subsequent molecular docking simulations. Me3SnL has been evaluated for its in vitro anticancer activity against three human cell lines, MCF-7 (breast adenocarcinoma), A375 (melanoma) and HCT116 (colorectal carcinoma), and three mouse tumor cell lines, 4T1 (breast carcinoma), B16 (melanoma) and CT26 (colon carcinoma), using MTT and CV assays. The strong inhibition of A375 cell proliferation, ROS/RNS upregulation and robust lipid peroxidation lead to autophagic cell death upon treatment with Me3SnL.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph17030372</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Analysis ; Antimitotic agents ; Antineoplastic agents ; Apoptosis ; Autophagy (Cytology) ; Chemical properties ; Diagnosis ; Drug therapy ; Melanoma ; Patient outcomes ; Structure ; Testing</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2024-03, Vol.17 (3)</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kasalović, Marijana P</creatorcontrib><creatorcontrib>Dimić, Dušan</creatorcontrib><creatorcontrib>Jelača, Sanja</creatorcontrib><creatorcontrib>Maksimović-Ivanić, Danijela</creatorcontrib><creatorcontrib>Mijatović, Sanja</creatorcontrib><creatorcontrib>Zmejkovski, Bojana B</creatorcontrib><creatorcontrib>Schreiner, Simon H. F</creatorcontrib><creatorcontrib>Rüffer, Tobias</creatorcontrib><creatorcontrib>Pantelić, Nebojša Đ</creatorcontrib><creatorcontrib>Kaluđerović, Goran N</creatorcontrib><title>Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells</title><title>Pharmaceuticals (Basel, Switzerland)</title><description>A novel trimethyltin(IV) complex (Me3SnL), derived from 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoate ligand, has been synthesized and characterized by elemental microanalysis, UV/Vis spectrophotometry, FT-IR and multinuclear ([sup.1] H, [sup.13] C and [sup.119] Sn) NMR spectroscopies. Furthermore, the structure of the ligand precursor HL was solved using SC-XRD (single-crystal X-ray diffraction). The prediction of UV/Vis and NMR spectra by quantum-chemical methods was performed and compared to experimental findings. The protein binding affinity of Me3SnL towards BSA was determined by spectrofluorometric titration and subsequent molecular docking simulations. Me3SnL has been evaluated for its in vitro anticancer activity against three human cell lines, MCF-7 (breast adenocarcinoma), A375 (melanoma) and HCT116 (colorectal carcinoma), and three mouse tumor cell lines, 4T1 (breast carcinoma), B16 (melanoma) and CT26 (colon carcinoma), using MTT and CV assays. The strong inhibition of A375 cell proliferation, ROS/RNS upregulation and robust lipid peroxidation lead to autophagic cell death upon treatment with Me3SnL.</description><subject>Analysis</subject><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Autophagy (Cytology)</subject><subject>Chemical properties</subject><subject>Diagnosis</subject><subject>Drug therapy</subject><subject>Melanoma</subject><subject>Patient outcomes</subject><subject>Structure</subject><subject>Testing</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjE1Lw0AYhBdRsFYv_oIFz9H9zGaPIX5UaNFD7-Xt5k2zstmEbAr67w3qoQeZwwzDM0PILWf3Ulr2MLTcMMmkEWdkwZVQWSGUOT_Jl-QqpQ_GtOGKL0jYjr7Dqf0Kk4_D2A8Qe5iQVnBMmOjaD76m7zj2n76Gyfcx22DtZ6Km5XHqhxYO3tEKQ6CPCFNLfaSrYweRbjDMXx3QUhr9Q6RrctFASHjz50uyfX7aVqts_fbyWpXr7JAbmSnU2hZOgrLCKgkc3Z7lUGgthWLWab23mmmWayu1sMiNAmF4vkfJVSOFXJK739sDBNz52PTTCK7zye1KUxRCC1HImbr_h5pVY-ddH7Hxc38y-AatW2dI</recordid><startdate>20240301</startdate><enddate>20240301</enddate><creator>Kasalović, Marijana P</creator><creator>Dimić, Dušan</creator><creator>Jelača, Sanja</creator><creator>Maksimović-Ivanić, Danijela</creator><creator>Mijatović, Sanja</creator><creator>Zmejkovski, Bojana B</creator><creator>Schreiner, Simon H. F</creator><creator>Rüffer, Tobias</creator><creator>Pantelić, Nebojša Đ</creator><creator>Kaluđerović, Goran N</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20240301</creationdate><title>Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells</title><author>Kasalović, Marijana P ; Dimić, Dušan ; Jelača, Sanja ; Maksimović-Ivanić, Danijela ; Mijatović, Sanja ; Zmejkovski, Bojana B ; Schreiner, Simon H. F ; Rüffer, Tobias ; Pantelić, Nebojša Đ ; Kaluđerović, Goran N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g673-4e5598c3a492943a1ecb06a85532409c55b950506593529e174a2716be314f323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Autophagy (Cytology)</topic><topic>Chemical properties</topic><topic>Diagnosis</topic><topic>Drug therapy</topic><topic>Melanoma</topic><topic>Patient outcomes</topic><topic>Structure</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kasalović, Marijana P</creatorcontrib><creatorcontrib>Dimić, Dušan</creatorcontrib><creatorcontrib>Jelača, Sanja</creatorcontrib><creatorcontrib>Maksimović-Ivanić, Danijela</creatorcontrib><creatorcontrib>Mijatović, Sanja</creatorcontrib><creatorcontrib>Zmejkovski, Bojana B</creatorcontrib><creatorcontrib>Schreiner, Simon H. F</creatorcontrib><creatorcontrib>Rüffer, Tobias</creatorcontrib><creatorcontrib>Pantelić, Nebojša Đ</creatorcontrib><creatorcontrib>Kaluđerović, Goran N</creatorcontrib><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kasalović, Marijana P</au><au>Dimić, Dušan</au><au>Jelača, Sanja</au><au>Maksimović-Ivanić, Danijela</au><au>Mijatović, Sanja</au><au>Zmejkovski, Bojana B</au><au>Schreiner, Simon H. F</au><au>Rüffer, Tobias</au><au>Pantelić, Nebojša Đ</au><au>Kaluđerović, Goran N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><date>2024-03-01</date><risdate>2024</risdate><volume>17</volume><issue>3</issue><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>A novel trimethyltin(IV) complex (Me3SnL), derived from 3-(4-methyl-2-oxoquinolin-1(2H)-yl)propanoate ligand, has been synthesized and characterized by elemental microanalysis, UV/Vis spectrophotometry, FT-IR and multinuclear ([sup.1] H, [sup.13] C and [sup.119] Sn) NMR spectroscopies. Furthermore, the structure of the ligand precursor HL was solved using SC-XRD (single-crystal X-ray diffraction). The prediction of UV/Vis and NMR spectra by quantum-chemical methods was performed and compared to experimental findings. The protein binding affinity of Me3SnL towards BSA was determined by spectrofluorometric titration and subsequent molecular docking simulations. Me3SnL has been evaluated for its in vitro anticancer activity against three human cell lines, MCF-7 (breast adenocarcinoma), A375 (melanoma) and HCT116 (colorectal carcinoma), and three mouse tumor cell lines, 4T1 (breast carcinoma), B16 (melanoma) and CT26 (colon carcinoma), using MTT and CV assays. The strong inhibition of A375 cell proliferation, ROS/RNS upregulation and robust lipid peroxidation lead to autophagic cell death upon treatment with Me3SnL.</abstract><pub>MDPI AG</pub><doi>10.3390/ph17030372</doi></addata></record>
fulltext fulltext
identifier ISSN: 1424-8247
ispartof Pharmaceuticals (Basel, Switzerland), 2024-03, Vol.17 (3)
issn 1424-8247
1424-8247
language eng
recordid cdi_gale_infotracmisc_A788252283
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central Free
subjects Analysis
Antimitotic agents
Antineoplastic agents
Apoptosis
Autophagy (Cytology)
Chemical properties
Diagnosis
Drug therapy
Melanoma
Patient outcomes
Structure
Testing
title Trimethyltinpropanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A38%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trimethyltinpropanoate%20Causes%20Lipid%20Peroxidation-Mediated%20Autophagic%20Cell%20Death%20in%20Human%20Melanoma%20A375%20Cells&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=Kasalovi%C4%87,%20Marijana%20P&rft.date=2024-03-01&rft.volume=17&rft.issue=3&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph17030372&rft_dat=%3Cgale%3EA788252283%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g673-4e5598c3a492943a1ecb06a85532409c55b950506593529e174a2716be314f323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A788252283&rfr_iscdi=true